THE WHAT? Dow has announced an exclusive agreement with Locus Performance Ingredients to sell its line of high-performance and multifunctional soporolipid biosurfactants in the global personal care market.
THE DETAILS The ingredients offer a substantial reduction in carbon footprint relative to conventional surfactants.
“Today’s consumers are looking for personal care products that can offer a hygiene factor as well as caring properties to their skin or hair,” said Isabel Almiro do Vale, Global Marketing and Strategy Director for Dow Personal Care. “This partnership with Locus PI, an unrivaled expert in biosurfactants and fermentation, complements our innovation, strength and strong position in the personal care market. The addition of Locus PI’s biosurfactants allows us to further deliver on our promise to develop products that are safe for people and the planet while accelerating the transition towards a low-carbon, circular economy.”
THE WHY? The partnership will allow both companies to leverage their key expertise, combining Locus PI’s fermentation know-how and ability to develop tailored biosurfactant ingredients with Dow’s penetration in the personal care market and formulation expertise.
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
